Through direct lobbying, public affairs campaigns, strategic collaborations and community programs, CLS works with government, industry, academia and other stakeholders to shape sound public policy that advances innovation, to promote equity and diversity, to support job creation and skills development and to advocate for all facets of the life sciences within the state of California and beyond.

Latest CLS Policy and Advocacy Updates

Advocacy Uncategorized

Meet and Greet with David Montes, Sen. Padilla’s Chief of Staff

On Monday, March 18 CLS held a roundtable conversation with David Montes, Chief of Staff to Senator Alex Padilla (D-CA)....
Read More
Advocacy Uncategorized

CLS Joins the SMTA Fly-In

Last week, CEO Mike Guerra and the CLS Federal team joined the AdvaMed State MedTech Alliance for its annual Capitol...
Read More
Advocacy Uncategorized

MedTech Day 2024

On February 13, California Life Sciences hosted our third annual MedTech Day, in partnership with AdvaMed. The day began with industry...
Read More
Advocacy Uncategorized

CLS host it’s 11th annual Life Sciences Academy

February 27th & 28th, CLS hosted its 11th annual Life Sciences Academy in Napa. This signature event brings together California...
Read More
Advocacy Uncategorized

Tax Relief for American Families and Workers Act – Letter

CLS brought together 76 life sciences leaders throughout California to author a letter to Senators Alex Padilla and Laphonza Butler,...
Read More
Advocacy Uncategorized

Help reinstate immediate R&D expensing

Since 2022, businesses have been prevented from immediately deducting their domestic R&D expenses. Negotiators are actively working to reverse this...
Read More

About Our Federal and State Advocacy Teams

CLS Advocacy BenefitsCalifornia Life Sciences’ team of experienced government relations professionals located in Sacramento, Washington, D.C., and throughout California’s regional municipalities, directly engage with policymakers on issues of critical importance to our members and the continued success of California’s life sciences sector. We engage on federal policy and regulatory items in accordance with the legislative priorities and recommendations of our membership including direct lobbying in Washington, D.C., position and coalition letters, comments and testimony.

The CLS Federal Legislative Committee (FLC) is the primary interface between our membership and identification of the policy items pertinent to CLS’s missions and objectives. The FLC meets monthly to discuss and develop positions and activities regarding federal legislative and regulatory issues of importance to our membership. The FLC also plays an integral role in the development of CLS’s annual federal policy, education, and advocacy agenda.

Our experienced state government relations team engages on behalf of the life sciences sector in multiple ways through strategic collaborations and direct lobbying in Sacramento to advance innovation, investment and job creation for California’s life sciences ecosystem.

In conjunction with the State Legislative Committee (SLC), we identify and develop position statements on issues of interest to CLS’ membership. This SLC group is composed of government affairs professionals at CLS member organizations.

In addition, we aim to favorably shape the policy environment for California’s life sciences industry by creating and leveraging a world class seamless advocacy, public affairs, and government relations program. The team advances a pro-innovation policy agenda, while ensuring patients have access to the right treatment at the right time.


California Life Sciences’ experienced local government relations team engages on behalf of the life sciences sector in multiple ways to advance the innovation, investment, and job creation for California’s life sciences ecosystem.

Local governmental bodies have an increasingly significant impact on the health and growth of California’s life sciences sector. To ensure our voice is heard, CLS provides representation and ensures ongoing dialogue between the industry and local elected officials and agencies throughout California.

Policy and Advocacy News

California Life Sciences Urges Congress to Support Rare Disease Patients

Oct 12, 2023

California Life Sciences (CLS) is pleased to support the Optimizing Research Progress Hope and New (ORPHAN) Cures Act, introduced by Reps. John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC). The bipartisan..

Read More

CLS statement following CMS announcement first drugs subject to price negotiation process

Aug 29, 2023

August 29, 2023 Today’s announcement by the Centers for Medicare and Medicaid Services is another disappointing step in the administration’s price-setting agenda which will irreversibly harm innovation. While CMS has..

Read More

Contact Us

Sam Chung
Vice President, State Government Relations
[email protected]